These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25364499)

  • 41. Therapeutic gene editing: delivery and regulatory perspectives.
    Shim G; Kim D; Park GT; Jin H; Suh SK; Oh YK
    Acta Pharmacol Sin; 2017 Jun; 38(6):738-753. PubMed ID: 28392568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome editing using artificial site-specific nucleases in zebrafish.
    Hisano Y; Ota S; Kawahara A
    Dev Growth Differ; 2014 Jan; 56(1):26-33. PubMed ID: 24117409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of CRISPR/Cas9 for biomedical discoveries.
    Riordan SM; Heruth DP; Zhang LQ; Ye SQ
    Cell Biosci; 2015; 5():33. PubMed ID: 26137216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Advances in genetic modification technologies].
    Zhang B; Sun Q; Li H
    Sheng Wu Gong Cheng Xue Bao; 2015 Aug; 31(8):1162-74. PubMed ID: 26762038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current status of genome editing in vector mosquitoes: A review.
    Reegan AD; Ceasar SA; Paulraj MG; Ignacimuthu S; Al-Dhabi NA
    Biosci Trends; 2017 Jan; 10(6):424-432. PubMed ID: 27990003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.
    Brookhouser N; Raman S; Potts C; Brafman DA
    Cells; 2017 Feb; 6(1):. PubMed ID: 28178187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engineered Viruses as Genome Editing Devices.
    Chen X; Gonçalves MA
    Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Research advance and application in the gene therapy of gene editing technologies].
    Ren YX; Xiao RD; Lou XM; Fang XD
    Yi Chuan; 2019 Jan; 41(1):18-27. PubMed ID: 30686782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution in crop improvement approaches and future prospects of molecular markers to CRISPR/Cas9 system.
    Dheer P; Rautela I; Sharma V; Dhiman M; Sharma A; Sharma N; Sharma MD
    Gene; 2020 Aug; 753():144795. PubMed ID: 32450202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
    Ul Ain Q; Chung JY; Kim YH
    J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genome Editing Tools and their Application in Experimental Ophthalmology].
    Yanik M; Wende W; Stieger K
    Klin Monbl Augenheilkd; 2017 Mar; 234(3):329-334. PubMed ID: 28114701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of site-specific mutations in the rat genome via CRISPR/Cas9.
    Guan Y; Shao Y; Li D; Liu M
    Methods Enzymol; 2014; 546():297-317. PubMed ID: 25398346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of genome editing technologies to the study and treatment of hematological disease.
    Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
    Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Precise Genome Modification via Sequence-Specific Nucleases-Mediated Gene Targeting for Crop Improvement.
    Sun Y; Li J; Xia L
    Front Plant Sci; 2016; 7():1928. PubMed ID: 28066481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current status and perspectives of genome editing technology for microalgae.
    Jeon S; Lim JM; Lee HG; Shin SE; Kang NK; Park YI; Oh HM; Jeong WJ; Jeong BR; Chang YK
    Biotechnol Biofuels; 2017; 10():267. PubMed ID: 29163669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient edition of the bovine PRNP prion gene in somatic cells and IVF embryos using the CRISPR/Cas9 system.
    Bevacqua RJ; Fernandez-Martín R; Savy V; Canel NG; Gismondi MI; Kues WA; Carlson DF; Fahrenkrug SC; Niemann H; Taboga OA; Ferraris S; Salamone DF
    Theriogenology; 2016 Nov; 86(8):1886-1896.e1. PubMed ID: 27566851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.